The potent antibacterial activity of sitafloxacin against fluoroquinolone-resistant clinical isolates of Vibrio cholerae O1

Microbiology and Immunology

Volumn 51, Issue 4, 2007, Pages 467-469

  Okuda, Jun ^a,d   Ramamurthy, Thandavarayan ^b   Yamasaki, Shinji ^c  

^a DAIICHI SANKYO CO   (Japan)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c Osaka Prefecture University   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Fluoroquinolone resistance; Sitafloxacin; Vibrio cholerae O1

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; QUINOLONE DERIVATIVE; SITAFLOXACIN; SPARFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENTEROPATHOGENIC ESCHERICHIA COLI; IN VITRO STUDY; INFECTION; NONHUMAN; VIBRIO CHOLERAE;

VIBRIO CHOLERAE;

EID: 34247390703     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb03921.x     Document Type: Article

References (10)

1. Akasaka, T., Kurosaka, S., Uchida, Y., Tanaka, M., Sato, K., and Hayakawa, I. 1998. Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases. Antimicrob. Agents Chemother. 42: 1284-1287.
2. Garg, P., Sinha, S., Chakraborty, R., Bhattacharya, S.K., Nair, G.B., Ramamurthy, T., and Takeda, Y. 2001. Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrob. Agents Chemother. 45: 1605-1606.
3. Kam, K.M., Luey, K.Y., Cheung, T.L., Ho, K.Y., Mak, K.H., and Saw, P.T. 1999. Ofloxacin-resistant Vibrio cholerae O139 in Hong Kong. Emerg. Infect. Dis. 5: 595-597.
4. Knapp, J.S., Hale, J.A., Neal, S.W., Wintersheid, K., Rice, R.J., and Whittington, W.L. 1995. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob. Agents Chemother. 39: 2442-2445.
5. Mukhopadhyay, A.K., Basu, I., Bhattacharya, S.K., Bhattacharya, M.K., and Nair, G.B. 1998. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India. Antimicrob. Agents Chemother. 42: 206-207.
6. Nakane, T., Iyobe, S., Sato, K., and Mitsuhashi, S. 1995. In vitro antibacterial activity of DU-6859a, a new fluoroquinolone. Antimicrob. Agents Chemother. 39: 2822-2826.
7. National Committee for Clinical Laboratory Standards. 1998. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4-J, 4th ed, National Committee for Clinical Latoratory Standards, Villanova, Pa.
8. Sato, K., Hoshino, K., Tanaka, M., Hayakawa, I., and Osada, Y. 1992. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob. Agents Chemother. 36:1491-1498.
9. Tanaka, M., Hoshino, K., Hohmura, M., Ishida, H., Kitamura, A., Sato, K., Hayakawa, I., and Nishino, T. 1996. Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method. J. Antimicrob. Chemother. 37: 1091-1102.
10. Yamamoto, T., Nair, G.B., Albert, M.J., Parodi, C.C., and Takeda, Y. 1995. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents. Antimicrob. Agents Chemother. 39: 241-244.